Table 6.

Clinical response of patients receiving fowlpox virus immunization^a

	Fowlpox virus encoding
			rF-gp100: ER209-2M
	rF-gp100 i.v.	rF-Mgp100 i.v.	i.v.	i.m
Virus alone
Total	8b	15	11	12
Responder	0	1	0	0
Cross-over to IL-2
Total	2	11	7	5
Responder	0	0	3	3
Complete	0	0	2	1
Partial	0	0	1	2

^aPatients received 5–6 × 10⁹ plaque-forming units of fowlpox virus i.v. or i.m. every 2–4 weeks; followup as of 4/1/02; no prior gp100 immunization in any patient.

^bValues represent number of patients.